Soybean mosaic virus resistance gene GmMATE and application thereof
By overexpressing the GmMATE gene in soybeans, the problem of insufficient resistance to soybean mosaic virus is solved, the resistance and growth ability are significantly improved, and effective genetic resources are provided for breeding.
Patent Information
- Application Number
- CN202411210124.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-08-30
AI Technical Summary
The prior art is difficult to effectively improve the resistance of soybeans to soybean mosaic virus, resulting in serious impacts on plant growth and yield, lack of effective chemical prevention and control methods, and manual inoculation and identification during breeding process is time-consuming and labor-intensive and economical.
By identifying and overexpressing the GmMATE gene in soybeans, a recombinant expression vector was constructed to transform it in the target plant, and positive plants were screened to significantly improve the resistance of soybeans to soybean mosaic virus and reduce the virus content.
Through the overexpression of the GmMATE gene, the resistance of soybeans to soybean mosaic virus is significantly improved, the virus content is reduced, the growth and development ability of the plants is enhanced, and reliable genetic resources are provided for disease-resistant breeding.
Smart Images

Figure CN118931949A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of molecular biology, in particular to a gene capable of improving the antiviral performance of soybean and application thereof. Background Art
[0002] Plants have developed a variety of defense mechanisms in response to infection by pathogens. According to the host's response to infection by pathogens, defense mechanisms can be divided into two categories: resistance to infection (vertical resistance) and resistance to expansion (horizontal resistance). There are obvious differences between the two defense mechanisms. Resistance to infection is to limit the pathogen to the area around the infection point so that it cannot expand systemically. Resistance to expansion allows the virus to complete systemic infection, but limits the virus content to a lower level to reduce the harm to plant growth and development, or compensates for the damage caused by the virus to a certain extent by adjusting its own metabolism and other physiological mechanisms, thereby reducing the harmful effects on plant growth, reproduction and yield (Martin et al. 2003; Salomon 1999).
[0003] Soybean mosaic disease is one of the major epidemic diseases of soybeans and occurs widely throughout the world. Soybean mosaic virus (SMV) is the main pathogen causing soybean mosaic disease. Infection will cause soybean yield reduction, quality decline, and even crop failure. At present, there is no effective chemical control method for viral diseases caused by SMV on soybeans, and prevention and control are the main methods. Therefore, breeding disease-resistant varieties has become the most economical and effective means. In order to reduce the harm of soybean mosaic disease in production, breeders use artificial inoculation to identify the resistance of varieties to be used for production and promotion. The virus strains used are generally local popular strains. The disease index (DI) is used to grade the resistance of varieties (Bai Li et al. 2007; Zhi Haijian et al., 2005; Li Kai et al., 2013). However, this artificial inoculation identification method is time-consuming and labor-intensive, and is located in the late stage of breeding selection. Once the disease is identified, the previous work will be wasted. Molecular marker-assisted breeding is currently considered to be a breeding strategy with broad application prospects (He et al. 2014; Ottoman et al. 2009; Fan et al. 2004), but its premise is to discover and identify genes with important breeding value. Therefore, domestic and foreign scholars have carried out extensive research on SMV resistance genes. For example, foreign scholars used G strains to identify three reliable loci, namely Rsv1, Rsv3 and Rsv4 (Yu et al. 1994; Jeong et al. 2002, Jeong and Maroof, 2004; Maroof et al. 2010). Based on the gene-to-gene theory (Flor, 1971), domestic scholars have also identified more than 10 resistance genes for specific SC strains in soybean (Wang et al. 2011; Wang Dagang et al., 2014; Yang et al. 2010, 2013; Zheng et al. 2014).
[0004] Necrosis is a common symptom of soybean mosaic disease. Although hypersensitive response (HR) is generally considered to be a plant response related to disease resistance, there are also some examples showing that HR is not related to disease resistance and HR symptoms can be caused by multiple pathways (Morel et al. 1997). In addition, although the specific molecular mechanism and effect of HR are still unclear, it can be determined that some stress defense reactions will produce secondary metabolites that are harmful to plant cells, including reactive oxygen intermediates, phytoalexins and salicylic acid (Ward et al. 1991). When these harmful metabolites accumulate to a certain amount, they will cause cell death, thus presenting HR or HR-like reactions. Therefore, it is very important for plant life activities to exclude these harmful toxins or substances from cells and maintain them within a dose that cells can tolerate (Hill. 2011). The MATE transporter family is a class of genes involved in the efflux of toxins and other metabolites (He et al. 2010). MATE (Multidrug and Toxic Compound Extrusion Transporter) family genes encode citrate transporters that respond to some biotic and abiotic stresses, including aluminum stress and phosphorus and iron deficiency (Santos et al. 2017; Zhou et al. 2014; MARON et al. 2013; Qiu et al. 2017). In Arabidopsis, overexpression of MATE family genes in rice not only increased plant growth rate and morphology, but also increased the sensitivity of plants to biotic and abiotic stresses, and significantly reduced the expression of defense-related genes (Tiwari et al). Studies have also shown that MATE transporters can protect cells from oxidative stress (Rodríguez-Beltrán et al. 2012), which is highly correlated with plant disease symptoms. At present, the biological role of MATE family genes in resistance to soybean mosaic disease has not been reported.
[0005] In summary, the research on genes related to soybean antiviral properties and the development of subsequent related applications is a technical hotspot and difficulty that urgently needs to be addressed. Summary of the invention
[0006] The technical problem to be solved by the present invention is to provide a gene capable of improving the antiviral performance of soybean and its application.
[0007] In order to solve the above technical problems, the technical solutions adopted by the present invention are as follows.
[0008] The invention comprises a soybean mosaic virus resistance gene, and its nucleotide sequence is shown in SEQ ID NO.1 (sequence table in xml format).
[0009] The present invention also includes homologous genes of the soybean mosaic virus resistance gene or known or unknown genes with biological equivalence.
[0010] The present invention also includes RNA corresponding to the above-mentioned gene, including messenger RNA and / or other long-chain or short-chain RNA and / or functional RNA.
[0011] The present invention also includes the protein or polypeptide expressed by the above gene.
[0012] The present invention also includes the use of the above gene in improving or reducing the resistance of target plants to soybean mosaic virus.
[0013] As a preferred technical solution of the present invention, the target gene shown in SEQ ID NO.1 is overexpressed in the target plant to improve the resistance of the target plant to soybean mosaic virus.
[0014] As a preferred technical solution of the present invention, an overexpression vector containing the nucleotide sequence shown in SEQ ID NO: 1 is first constructed, and then a transformant is constructed using the overexpression vector. The resulting transformant is then used to infect the root system of a recipient plant, and positive plants are screened to obtain transgenic plants with enhanced soybean mosaic virus resistance compared to normal plants.
[0015] As a preferred technical solution of the present invention, specifically, 35S is used as a promoter, the CDS sequence of the target gene is constructed into the overexpression vector PTF101, the obtained recombinant expression vector is expressed in the disease-susceptible soybean variety Nannong 1138-2, positive plants are screened, and transgenic plants with enhanced soybean mosaic virus resistance compared with normal plants are obtained.
[0016] The present invention also includes a recombinant expression vector, including a backbone vector and the gene according to claim 1 or 2 or its equivalent nucleotide sequence.
[0017] The present invention also includes engineering bacteria, transformants or other intermediates of molecular biological operations containing the above-mentioned gene or recombinant expression vector.
[0018] The beneficial effect of adopting the above technical scheme is that the present invention develops and confirms the efficacy of a gene named GmMATE in resistance to soybean mosaic virus. In our previous research work, through QTL positioning, a QTL locus that affects the necrosis symptoms caused by mosaic virus infection was identified; on this basis, this study, through further in-depth research, based on family analysis, gene expression, transgenic and other means, finally confirmed that GmMATE (gene number: Glyma.03G005600) is its key regulatory gene, which has important scientific research and practical value. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 This is a tissue expression analysis diagram of 6 MATE candidate genes.
[0020] Figure 2 This is the experimental map for the correlation analysis between the qTsmv-3 locus and the salicylic acid resistance pathway.
[0021] Figure 3 This is the experimental map of Glyma.03G005600 transformation into Arabidopsis thaliana.
[0022] Figure 4 This is a detection picture of a genetically modified positive soybean plant.
[0023] Figure 5 Schematic diagram of the main nodes of soybean genetic transformation technology operation.
[0024] Figure 6 This is a detection chart of target gene expression and virus content in overexpression strains in soybean. DETAILED DESCRIPTION
[0025] The present invention is described in detail in the following examples. All raw materials and equipment used in the present invention are conventional commercial products and can be directly obtained through market purchase.
[0026] It should be understood that the term “and / or” used in the specification and appended claims of this application refers to any and all possible combinations of one or more of the associated listed items, and includes these combinations.
[0027] As used in the specification and appended claims of this application, the term "if" can be interpreted as "when" or "uponce" or "in response to determining" or "in response to detecting", depending on the context. Similarly, the phrase "if it is determined" or "if [described condition or event] is detected" can be interpreted as meaning "uponce it is determined" or "in response to determining" or "uponce [described condition or event] is detected" or "in response to detecting [described condition or event]", depending on the context.
[0028] In addition, in the description of the present application specification and the appended claims, the terms "first", "second", "third", etc. are only used to distinguish the descriptions and cannot be understood as indicating or implying relative importance.
[0029] References to "one embodiment" or "some embodiments" etc. described in the specification of this application mean that one or more embodiments of the present application include specific features, structures or characteristics described in conjunction with the embodiment. Therefore, the phrases "in one embodiment", "in some embodiments", "in some other embodiments", "in some other embodiments", etc. appearing in different places in this specification do not necessarily refer to the same embodiment, but mean "one or more but not all embodiments", unless otherwise specifically emphasized in other ways.
[0030] The terms "include", "comprising", "having" and variations thereof all mean "including but not limited to", unless specifically emphasized otherwise.
[0031] Example 1. Analysis of expression characteristics of MATE candidate genes at the qTsmv-3 locus
[0032] In our previous research, we identified a QTL locus qTsmv-3 that affects the necrosis symptoms caused by mosaic virus infection through QTL positioning.
[0033] On this basis, this study finally confirmed that GmMATE (gene number: Glyma.03G005600) is its key regulatory gene through family analysis, gene expression, transgenic and other methods.
[0034] First, in order to clarify the evolutionary characteristics of MATE family genes in the soybean genome, a total of 128 MATE family genes were predicted on the public genome Williams82v2.1 (https: / / phytozome-next.jgi.doe.gov / ), and the corresponding protein sequences were downloaded. At the same time, phylogenetic evolution analysis was performed with 12 MATE family genes reported in Arabidopsis, rice, rapeseed, tobacco, barley and corn. The results showed that the 128 soybean MATE family genes can be significantly divided into five subfamilies.
[0035] The six MATE candidate genes (CG1-CG6) within the qTsmv-3 locus were predicted on a public database website (https: / / soyatlas.venanciogroup.uenf.br). The expression results based on 4124 samples showed that the six candidate genes showed certain differences in tissue expression. Figure 1, from the analysis of expression level, CG5 is expressed at a higher level in leaves and stems above ground, while CG6 is expressed at a higher level in roots and nodules below ground. In addition, from the analysis of the main expression sites, CG1, CG2, CG4 and CG5 are similar, mainly expressed in the aboveground parts, while the expression levels in the roots are relatively low or almost non-existent. CG3 is significantly expressed both above and below ground. The above results indicate that there are differences in the main organs in which the six MATEs function, suggesting that the biological functions of some genes are also different.
[0036] Example 2. Correlation analysis between qTsmv-3 locus and salicylic acid resistance pathway
[0037] In order to further analyze whether the regulation of SMV necrosis symptoms by the qTsmv-3 locus is related to the salicylic acid (SA) resistance pathway, the insemination lines of the qTsmv-3 locus were used as materials, and the expression levels of the indicator genes ICS and PR1 in the SA resistance pathway were analyzed after inoculation with the SMV strain SC3. The results showed that ( Figure 2 A), the symptoms of the near-isogenic lines showed obvious differences 25 days after inoculation. No obvious necrotic symptoms were observed in the inoculated leaves and upper leaves of #NIL-SMC. Obvious mosaic symptoms were observed 7 days after inoculation. 25 days after inoculation, the upper leaves showed obvious mosaic and wrinkling, two typical disease symptoms. In contrast, #NIL-NC showed mild mosaic symptoms 7 days after inoculation, but then necrotic spots appeared in the mesophyll, and some of them were necrotic along the veins. This is basically consistent with our previous observations (Lin et al., 2021). Expression analysis results showed that after inoculation, the expression levels of ICS and PR1 in #NIL-NC were upregulated by 2.40 and 15.16 times respectively compared with #NIL-SMC ( Figure 2 B, C), indicating that there are significant differences in the SA disease resistance process between #NIL-NC and #NIL-SMC. In addition, the concentration of SC3 in #NIL-NC leaves is about 30% of that in #NIL-SMC, indicating that the difference in the SA disease resistance process between near-isogenic lines affects the virus content in the leaves ( Figure 2 D). The above results indicate that the qTsmv-3 locus is involved in the SA-mediated resistance to SMV.
[0038] Example 3. Experimental verification in model plants
[0039] In order to further verify the biological function of Glyma.03G005600 and whether it is involved in the SA disease resistance process, Glyma.03G005600 was transformed into Arabidopsis thaliana (Genetic Resource Source Disclosure Registration Form) for observation.
[0040] The results showed that the leaf number, leaf size, root size and total biomass of the transgenic plants (OE_MATE) were significantly greater than those of the wild type (WT) ( Figure 3A, B), indicating that Glyma.03G005600 can promote plant growth and development. In addition, about 7 days after ultraviolet (UV-B) treatment, the leaves and stems of transgenic Arabidopsis plants showed obvious purple coloration, indicating that anthocyanins accumulated significantly, while the wild type (WT) did not show such a phenomenon. Further fluorescence quantitative detection of the indicator genes ICS1 and PR1 on the SA pathway at this stage showed that compared with plants not treated with UV-B, ICS1 and PR1 were significantly upregulated in transgenic and wild-type plants after UV-B treatment ( Figure 3 D, E). In the UV-B treatment group, the expression levels of ICS1 and PR1 in OE_MATE were significantly upregulated by 4.22 and 9.12 times compared with WT, respectively ( Figure 3 D, E), indicating that Glyma.03G005600 can significantly promote the synthesis of SA and the stress response process of the SA pathway.
[0041] Example 4. Verification of overexpression function in soybean
[0042] To further confirm the biological function of Glyma.03G005600 in the process of SMV resistance, the CDS sequence of Glyma.03G005600 cloned from Jidou 12 (Genetic Resource Source Disclosure Registration Form) was constructed into the overexpression vector PTF101 using 35S as the promoter, which is referred to as GmMATE. GmMATE was expressed in the soybean susceptible variety Nannong 1138-2 (Genetic Resource Source Disclosure Registration Form), and three overexpression lines were obtained ( Figure 4 Among them, the main nodes of soybean genetic transformation technology operation include (see Appendix Figure 5 ):
[0043] Preparation of infection solution: preparation of explants and bacterial solution to infect explants (3h), constant temperature incubation at 22 degrees (3days), bud recovery medium (7days), bud induction medium (21days), and bud elongation medium.
[0044] Soybean seed sterilization: Before sterilization, select beans: large and full, smooth and without holes, wrinkles, and cracks, then spread 6 culture medium dishes, put a large dryer in the fume hood, put a blue bottle without a lid in the middle of the dryer, put the culture dish with beans on the side, lift the lid and lean it against the dryer, first pour 90ml of NACLO into the blue bottle, then pour 10ml of concentrated HCL, and quickly cover the lid. Sterilize for 15-16 hours.
[0045] Preparation of infection solution: Prepare activated Agrobacterium, first introduce about 25-30ml infection solution (this is 100ml) into a 50ml centrifuge tube, scrape some bacterial solution from the culture dish with bacteria using a wire loop, put it into the bottle containing infection solution, shake well, measure the OD600 value, and finally adjust the bacterial solution OD = 0.6. After adjusting the OD value, pour it evenly into 2 clean and sterile culture dishes, 50ml each for standby use.
[0046] Preparation of soybean explants: Cut the soybean seeds germinated overnight in half in a clean bench, retaining the cotyledons, hypocotyls and embryos. The true leaves can also be removed to increase the wound. Put the cut beans into the invasive dye solution and let it stand for 3 hours.
[0047] Incubate at a constant temperature of 22 degrees: Drain the beans, and then place them in a new culture dish with the hypocotyl side facing up. Put 15 petals in a dish and put it in a constant temperature incubator at 22 degrees for 3 days.
[0048] Bud recovery: Take out the cotyledon node after incubation and observe whether bacteria grow. Use tweezers to pick up the sterile explant bean petal, with the embryo axis facing downward, and insert the bean petal vertically into the R0 medium, preferably with the plane facing in one direction. Seal it. Put it in the light culture room for 7 days.
[0049] Bud induction: Take out the cotyledon node with buds from the R0 culture medium. At this time, the hypocotyl and buds are elongated, and some have long roots. Place them on the lid of the culture dish, cut off the roots and cotyledons, and press the parts above the growth point node into the R1 culture medium, which contains the selection agent glufosinate. Culture in the photoculture chamber for 21 days.
[0050] Bud elongation stage: After screening in the bud induction stage, the successfully transformed plants will show Basta resistance. The surrounding aging and dead adventitious buds and leaves are cleaned and transferred to the bud elongation medium and cultured in the light culture room for 21 days.
[0051] Obtaining positive plants: The plants obtained at the bud elongation stage are tested for Basta resistance, and the positive plants are transferred to rooting medium and continue to be cultured until roots are formed. After rooting, they are transplanted.
[0052] The results of detecting the target gene expression levels of the three overexpression strains showed that ( Figure 6A), the expression levels of GmMATE in the three strains were significantly higher than those in the control, which were 11.37, 16.76 and 12.98 times higher than those in the control, respectively, indicating that the three transgenic strains overexpressed the target gene. After further inoculation and identification of the three overexpression strains, the soybean mosaic virus content was detected in the upper leaves. The results showed that compared with the wild type (WT), the soybean mosaic virus (SMV) content in the upper leaves of the overexpression strains showed a significant decrease, among which the virus concentration of #OE_1 was about 23.43% of that of WT, and the virus concentrations of #OE_2 and #OE_3 were 31.141% and 54.41% of that of WT. The results showed that after overexpressing the gene GmMATE, the concentration of SMV virus can be significantly inhibited. This provides a reliable resistance gene resource for subsequent disease resistance breeding.
[0053] In the above embodiments, the description of each embodiment has its own emphasis. For parts that are not described or recorded in detail in a certain embodiment, reference can be made to the relevant descriptions of other embodiments.
[0054] The embodiments described above are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features may be replaced by equivalents. Such modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention, and should all be included in the protection scope of the present invention.
Claims
1. A soybean mosaic virus resistance gene, the nucleotide sequence of which is shown in SEQ ID NO.
1.
2. A homologous gene of the soybean mosaic virus resistance gene of claim 1 or a known or unknown gene with biological equivalence.
3. RNA corresponding to the gene according to claim 1 or 2, including messenger RNA and / or other long-chain or short-chain RNA and / or functional RNA.
4. The protein or polypeptide expressed by the gene according to claim 1 or 2.
5. Use of the gene according to claim 1 or 2 in improving or reducing the resistance of a target plant to soybean mosaic virus.
6. The use according to claim 5, Features: The target plant is overexpressed with the target gene shown in SEQ ID NO.1 to improve the resistance of the target plant to soybean mosaic virus.
7. The use according to claim 6, Features: First, an overexpression vector containing the nucleotide sequence shown in SEQ ID NO: 1 is constructed, and then a transformant is constructed using the overexpression vector. The obtained transformant is then used to infect the root system of a recipient plant, and positive plants are screened to obtain transgenic plants with enhanced soybean mosaic virus resistance compared with normal plants.
8. The use according to claim 7, Features: Specifically, using 35S as a promoter, the CDS sequence of the target gene was constructed into the overexpression vector PTF101, the obtained recombinant expression vector was expressed in the disease-susceptible soybean variety Nannong 1138-2, positive plants were screened, and transgenic plants with enhanced soybean mosaic virus resistance compared with normal plants were obtained.
9. A recombinant expression vector comprising a backbone vector and the gene according to claim 1 or 2 or its equivalent nucleotide sequence.
10. An engineered bacterium, a transformant or other intermediate of molecular biological manipulation comprising the gene according to claim 1 or 2 or the recombinant expression vector according to claim 9.
Citation Information
Patent Citations
Sorghum aluminum tolerance gene, sbmate
CN101883572A
Snailflower citric acid transporter gene VuMATE and use thereof
CN102154318A
Plant expression vector of Tanba black soybean C2H2 zinc finger protein gene STOP1 and application thereof
CN102952822A
Soybean mosaic virus resistant gene GmNN1 and application of functional markers of soybean mosaic virus resistant gene GmNN1
CN105154450A
Application of GmMAPKKK gene to improvement of resistance of plants to soybean mosaic virus disease
CN107475288A
Cited By
Application of rape gene BnDTX19 in prevention and control of sclerotiniose
CN119752936A
Application of Brassica napus gene BnDTX19 in sclerotinia prevention and control
CN119752936B
